The Clorox Company (NYSE:CLX) Shares Sold by Glassman Wealth Services

Glassman Wealth Services trimmed its position in shares of The Clorox Company (NYSE:CLX) by 37.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 193 shares of the company’s stock after selling 116 shares during the period. Glassman Wealth Services’ holdings in Clorox were worth $28,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. First National Bank of Mount Dora Trust Investment Services lifted its stake in Clorox by 3.2% during the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock worth $322,000 after acquiring an additional 71 shares in the last quarter. Modera Wealth Management LLC boosted its stake in shares of Clorox by 1.4% in the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after purchasing an additional 71 shares during the period. Czech National Bank grew its holdings in shares of Clorox by 0.3% in the fourth quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after purchasing an additional 71 shares in the last quarter. Global Retirement Partners LLC increased its stake in Clorox by 7.2% during the 4th quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock worth $156,000 after buying an additional 73 shares during the period. Finally, West Branch Capital LLC lifted its holdings in Clorox by 9.3% during the 4th quarter. West Branch Capital LLC now owns 903 shares of the company’s stock worth $129,000 after buying an additional 77 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

CLX stock traded up $0.04 during trading on Thursday, hitting $139.67. The company had a trading volume of 2,055,399 shares, compared to its average volume of 1,264,719. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $178.21. The firm has a 50-day moving average price of $149.00 and a 200-day moving average price of $143.10. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The firm has a market cap of $17.33 billion, a PE ratio of 73.06, a price-to-earnings-growth ratio of 2.34 and a beta of 0.44.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The business had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 305.36%. The business’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.51 earnings per share. On average, analysts expect that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.44%. Clorox’s payout ratio is currently 248.71%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Barclays cut their price objective on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a research report on Thursday. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday. The Goldman Sachs Group assumed coverage on shares of Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective on the stock. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a report on Tuesday, March 26th. Finally, Evercore ISI decreased their price target on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a report on Wednesday. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and an average price target of $149.13.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.